Multiple Sclerosis

Multiple sclerosis (MS) is a severe autoimmune disease of the central nervous system that affects the brain and spinal cord, causing problems with muscle movement, balance and vision.

Multiple Sclerosis (MS)

Multiple sclerosis (MS) is a neurodegenerative disorder that damages the nerves in the brain and spinal cord, leading to problems with muscle movement, balance and vision.

Working Towards Earlier Diagnosis of Multiple Sclerosis

What Causes Multiple Sclerosis?

Multiple Sclerosis Epidemiology

Early Signs of Multiple Sclerosis

Multiple sclerosis and beta interferon

Primary Progressive Multiple Sclerosis (PPMS)

Secondary Progressive Multiple Sclerosis (SPMS)

See more featured articles »

Benign Multiple Sclerosis (MS)

Types of Multiple Sclerosis (MS)

Multiple Sclerosis and Pregnancy

Multiple Sclerosis in Children

Multiple Sclerosis and Women’s Health

At-Home Physiotherapy Exercises for Multiple Sclerosis

Epigenetics for Multiple Sclerosis

Anti-Myelin Antibodies in Multiple Sclerosis

Cognitive Impairment and Multiple Sclerosis

Remyelination Strategies for Multiple Sclerosis

Heat Intolerance in Multiple Sclerosis

Multiple sclerosis and smoking

Optic Neuritis and Multiple Sclerosis

How is RRMS Different from PPMS and SPMS?

Relapsing-Remitting Multiple Sclerosis (RRMS)

Latest Multiple Sclerosis News and Research

Discovery sheds light on protein's role in myelin formation and schizophrenia

Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and stability of myelin, suggesting an important impact on neurodegenerative diseases and mental disorders such as multiple sclerosis and schizophrenia.

17 Apr 2025

2025 Best Practices Update released for managing MS in a changing landscape

Keeping up with scientific advances and practice changes can be one the biggest challenges in managing a complex disease like multiple sclerosis (MS).

17 Apr 2025

Sex and age play key roles in dementia biomarker levels

A new study has found important clues about the roles age, sex, hormonal changes and genetics play in how certain biomarkers for dementia are expressed in the blood, according to a study published on April 16, 2025, online in Neurology, the medical journal of the American Academy of Neurology.

16 Apr 2025

UC researchers receive $200,000 grant to design user-friendly exoskeleton for spinal cord injury patients

For people with spinal cord injuries/diseases (SCI/D), performing daily tasks can be a challenge due to an impaired ability to grasp and manipulate objects with their hands.

16 Apr 2025

Heavy drinking linked to increased risk of brain lesions

Heavy drinkers who have eight or more alcoholic drinks per week have an increased risk of brain lesions called hyaline arteriolosclerosis, signs of brain injury that are associated with memory and thinking problems, according to a study published on April 9, 2025, online in Neurology®, the medical journal of the American Academy of Neurology.

9 Apr 2025

Study explores impact of parental Alzheimer’s on tau protein spread in the brain

While some studies have suggested that having a mother with Alzheimer's disease may put you more at risk of developing the disease, a new study finds that having a father with the disease may be tied to a greater spread of the tau protein in the brain that is a sign of the disease, according to a study published on April 9, 2025, online in Neurology®, the medical journal of the American Academy of Neurology.

9 Apr 2025

Breakthrough nanoparticle delivery method targets brain inflammation for multiple conditions

Oregon State University researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer's disease, multiple sclerosis, Parkinson's disease and cancer cachexia.

9 Apr 2025

Tolebrutinib shows promise for treating non-relapsing secondary progressive multiple sclerosis

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, demonstrated a 31% delay in the onset of six-month confirmed disability progression (CDP) in patients with non-relapsing secondary progressive multiple sclerosis (SPMS).

8 Apr 2025

Marathon running alters brain myelin for energy use

According to a study published by Nature Metabolism, marathon runners experience reversible changes in their brain myelin.

8 Apr 2025

AI tool helps track treatment progress in multiple sclerosis patients

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers.

7 Apr 2025

Racial and age disparities in cervical artery dissection hospitalizations

Cervical artery dissection is a tear in an artery in the neck that provides blood flow to the brain. Such a tear can result in blood clots that cause stroke. A new study has found almost a five-fold increase in the number of U.S. hospitalizations for cervical artery dissection over a 15-year period.

3 Apr 2025

Annual COVID-19 boosters crucial for immunocompromised individuals

New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain immunocompromised people, researchers at McGill University say.

1 Apr 2025

Cell's stress response is more nuanced and compartmentalized than previously thought

The body's cells respond to stress-toxins, mutations, starvation or other assaults-by pausing normal functions to focus on conserving energy, repairing damaged components and boosting defenses.

26 Mar 2025

COVID-derived molecular mimics may be involved in triggering autoimmunity

COVID infection has been linked to higher risk of autoimmune disorders, including rheumatoid arthritis and type 1 diabetes.

26 Mar 2025

Study finds association between heart dysfunction and smaller brain volumes

People who have early signs of heart problems may also have changes in brain health that can be early signs of dementia, such as loss of brain volume, according to a meta-analysis published on March 26, 2025, online in Neurology, the medical journal of the American Academy of Neurology.

26 Mar 2025

Neighborhood disadvantage linked to higher dementia risk

People living in more disadvantaged neighborhoods may be more likely to develop dementia than people living in neighborhoods with fewer disadvantages, according to a study published on March 26, 2025, online in Neurology, the medical journal of the American Academy of Neurology.

26 Mar 2025

New cannabis formula will help epilepsy, multiple sclerosis sufferers

Scientists at the University of South Australia have come up with an innovative solution to improve the effectiveness of cannabidiol to treat epilepsy, multiple sclerosis and other neurodegenerative diseases.

20 Mar 2025

Daytime sleepiness may double dementia risk in elderly women

For women in their 80s, experiencing increasing sleepiness during the day over a five-year period is associated with double the risk of developing dementia during that time, according to a study published on March 19, 2025, online in Neurology®, the medical journal of the American Academy of Neurology.

20 Mar 2025

Breakthrough in cannabidiol formulation improves treatment for epilepsy and MS

19 Mar 2025

Gamified mobile health app designed to help people with MS manage fatigue

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS) manage fatigue, one of the most common and debilitating symptoms of the disease.

18 Mar 2025